ANTINUCLEAR ANTIBODIES IN ASTHMA PATIENTS - A SPECIAL ASTHMA PHENOTYPE?

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AGACHE I.; DUCA L.; ANGHEL M.; PAMFIL GH.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Allergy, Asthma and Immunology Year:2009 | Volume:8 | Issue:1 Page(s): 49-52

Download Full-Text

View:

382

Download:

181

Cites:

Information Journal Paper

Title

ANTINUCLEAR ANTIBODIES IN ASTHMA PATIENTS - A SPECIAL ASTHMA PHENOTYPE?

Author(s)

AGACHE I. | DUCA L. | ANGHEL M. | PAMFIL GH. | Issue Writer Certificate

Keywords

ANTINUCLEAR ANTIBODIES

ASTHMA PHENOTYPE

RISK FACTORS

SEVEN ASTHMA

Abstract

Several studies reported the appearance of asthma and autoimmune conditions in the same patient, but the clinical significance of this association was not yet assessed.One hundred asthmatic patients were observed for one year evolution with death, severe exacerbations, intake of > 1000 micrograms of beclometasone or equivalent (high ICS) and FEV1 decline >100 ml, in relation with ANA (ELISA), sputum and blood eosinophilia (EO), NSAID intolerance, BMI >25, chronic rhinosinusitis, smoking status and FEV1 <30% predicted (low FEV1).After 1 year of observation, there were 5 deaths, 28 severe asthma exacerbations requiring hospitalisations, 24 cases requiring high inhaled corticosteroid intake, and 19 patients with fast FEV1 decline (>100 ml/year). Multiple regression analysis pointed out several different independent RISK FACTORS for severe asthma evolution: for death presence of ANA (P=0.037), NSAID intolerance (P<0.001) and low FEV1 (P=0.021); for evolution with severe exacerbations ANA (p=0.011), sputum EO (P<0.001), smoking (P=0.044) and NSAID intolerance (P=0.022); for high ICS intake ANA (P=0.036), sputum EO (P=0.026) and low FEV1 (P=0.006); for FEV1 decline >100 ml ANA (P=0.006), sputum EO (P=0.037), BMI>25 (P=0.046) and NSAID intolerance (P=0.017).The presence of ANA is an independent risk factor in asthma for evolution with death, severe exacerbations, high inhaled corticosteroid intake and FEV1 decline >100 ml.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

AGACHE, I., DUCA, L., ANGHEL, M., & PAMFIL, GH.. (2009). ANTINUCLEAR ANTIBODIES IN ASTHMA PATIENTS - A SPECIAL ASTHMA PHENOTYPE?. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), 8(1), 49-52. SID. https://sid.ir/paper/291230/en

Vancouver: Copy

AGACHE I., DUCA L., ANGHEL M., PAMFIL GH.. ANTINUCLEAR ANTIBODIES IN ASTHMA PATIENTS - A SPECIAL ASTHMA PHENOTYPE?. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI)[Internet]. 2009;8(1):49-52. Available from: https://sid.ir/paper/291230/en

IEEE: Copy

I. AGACHE, L. DUCA, M. ANGHEL, and GH. PAMFIL, “ANTINUCLEAR ANTIBODIES IN ASTHMA PATIENTS - A SPECIAL ASTHMA PHENOTYPE?,” IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), vol. 8, no. 1, pp. 49–52, 2009, [Online]. Available: https://sid.ir/paper/291230/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops